Friday, 16 Feb 2018

You are here

Increased Pulmonary Embolism Risk in Lupus Patients

Systemic lupus erythematosus (SLE) poses numerous vascular risks, many of which are thought to be autoantibody mediated.

A retrospective population-based analysis was done to determine the association of SLE and plumonary embolism (PE) using the National Hospital Discharge Survey data, a representative sample of hospital discharges throughout the United States.

Researchers identified PE cases for the period 2001 to 2010. Among those were identified as SLE (ICD-9 code 710.0) and PE (ICD-9 codes 415.11, 415.12, 415.13, and 415.19).

A significant association between SLE and PE, independent of sex, race, age, comorbidities, found a two-fold increase risk of PE (odds ratio [OR], 2.0; 95% confidence interval [CI], 1.99–2.16).

Patients with a primary hypercoagulable disorder had the greatest odds of PE (OR, 15.37; 95% CI, 15.22–15.51). A higher risk was seen in those of African American (AA) race (OR, 1.08, 95% 1.08–1.09), and presence of at least 1 of the comorbidities (OR, 1.06; 95% CI, 1.06–1.06).

Females, especially AA, had an overall higher prevalence of SLE-related PE (1.67%) compared with males (1.29%). This PE-SLE association was highest for females, blacks, and age group 35 to 44 years, respectively.

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

Nailfold Capillaroscopy Portends Prognosis in Systemic Sclerosis

Two reports underscore the importance of nailfold capillaroscopy (NFC) in scleroderma and have shown that nailfold capillary drop out was significantly associated with mortality in systemic sclerosis.

Poor Prognosis of the MDA-5 Antibody in Dermatomyositis

Researchers from Hong Kong assessed the clinical associations seen with the anti-melanoma differentiation-associated gene 5 antibody (anti-MDA5 Ab) assay in consecutive patients with dermatomyositis (DM) and polymyositis (PM).

Twenty patients with either DM or PM who were followed in the Rheumatology Clinic of Kwong Wah Hospital, Hong Kong were recruited and underwent testing for the anti-MDA-5 antibody.

Inefficacy of Immunosuppressive Treatments in Systemic Sclerosis with ILD

EUSTAR study results published in Arthritis Research & Therapy show the current state of immunosuppressive use in systemic sclerosis patients with interstitial lung disease (SSc-ILD) to be ill-defined, but that liberal use of glucocorticoids (GC) in SSc-ILD should be discouraged.

ESRD Death Declines in Vasculitis Patients

 

In the past 2 decades, mortality from end-stage renal disease (ESRD) among U.S. patients with granulomatosis with polyangiitis (GPA) has declined significantly, a nationwide study found.

Stroke Risk Confirmed in SLE

The most common cerebrovascular events (CVEs) seen among a large cohort of patients with systemic lupus erythematosus (SLE) were stroke and transient ischemia, and the majority of these events were attributable to the disease itself, a multinational study determined.